Developing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.

Learn More >

 

Rare Genetic Disorders of Obesity

Our lead peptide product candidate, setmelanotide, is a potent, first-in-class MC4R agonist for the treatment of rare genetic disorders of obesity.

LEARN ABOUT OUR PRODUCT PIPELINE >

 

FOR PHYSICIANS & PATIENTS

The Genetic Obesity Project website sponsored by Rhythm is dedicated to improving the understanding of severe obesity that is caused by specific genetic defects.

VISIT WEBSITE >

Developing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.

Learn More >